International Journal of Health and Allied Sciences
Abstract
Lack of independent biomarkers is very much evident in NAFLD. Early detection of NAFLD is difficult due to the absence of specific diagnostic and prognostic markers and clinical symptoms. We retrospectively collected the information of patients hospitalised with NAFLD diagnosis and metabolic syndrome during 2019-2020 using the tertiary care hospital inpatient sample database and evaluated the changes in their serum homocysteine levels. We found that 59.063% of NAFLD in the male population and 41.667% of NAFLD in the female population had increased serum homocysteine. This shows that elevated serum homocysteine can act as a potential biomarker for NAFLD.
Recommended Citation
H.K., Panchami; M, Kumara; Shiragannanavar, Varsha D.; Sannappagowda, Nirmala G.; Karunakara, Shreyas H.; Puttahanumantharayappa, Lakshana D.; K.S., Kusuma; N.K., Swetha; M.N., Suma; and Santhekadur, Prasanna K.
(2022)
"Elevated serum Homocysteine levels a possible non-invasive diagnostic biomarker in patients with Non-alcoholic fatty liver disease,"
International Journal of Health and Allied Sciences: Vol. 11:
Iss.
2, Article 5.
DOI: 10.55691/2278-344X.1025
Available at:
https://rescon.jssuni.edu.in/ijhas/vol11/iss2/5